ASH 65th Annual Meeting & Exposition: Friday Satellite Symposia


Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care

This program is supported by an educational grant from Genmab US, Inc. and AbbVie


3:00 p.m. - 6:00 p.m. Pacific time



San Diego Convention Center
Room 30 A-E

Access Program Details

This activity is intended to educate clinicians regarding the use and integration of new and emerging BCMA-targeted therapies in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). In the “Care Team Forum,” an expert panel will present 3 series of didactic slides, followed by discussion that will include a patient with R/R DLBCL; they will share key aspects of their therapeutic journey. Polling questions will be interspersed throughout the symposium to assess improvements in knowledge and competence among attendees.

Chair:

Joshua Brody, MD
Icahn School of Medicine at Mount Sinai
New York, NY

Speakers:

Lorenzo Falchi, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Lori A. Leslie, MD
Hackensack Meridian School of Medicine
Hackensack, NJ

Erika Sinofsky , RMEI Medical Education, LLC
Email: esinofsky@rmei.com